Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 6/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.44 |
| ▸ | APEX1 | P27695 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.35 |
| ▸ | GAA | P10253 | 2/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.32 |
| ▸ | CASP6 | P55212 | 1/20 | 0.32 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13346525 | 0.92 | POLB (0.35) | POLBTDP1APEX1ALDH1A1CYP2C19 | |
| SCHEMBL9223251 | 0.90 | POLB (0.52) | POLBTDP1APEX1ALDH1A1CYP2C19 | |
| SCHEMBL13346524 | 0.80 | MEN1 (0.32) | POLBTDP1 | |
| SCHEMBL13072107 | 0.78 | POLB (0.56) | POLBTDP1APEX1ALDH1A1CYP2C19 | |
| SCHEMBL13346669 | 0.78 | POLB (0.44) | POLBTDP1APEX1ALDH1A1SMN1; SMN2 | |
| SCHEMBL16229111 | 0.77 | PPM1B (0.41) | POLBTDP1APEX1ALDH1A1SMN1; SMN2 | |
| SCHEMBL13346522 | 0.76 | RAB9A (0.31) | — | |
| SCHEMBL13346677 | 0.75 | POLB (0.41) | POLBTDP1APEX1ALDH1A1SMN1; SMN2 | |
| SCHEMBL13346671 | 0.75 | POLB (0.41) | POLBTDP1APEX1ALDH1A1SMN1; SMN2 | |
| SCHEMBL9073184 | 0.73 | ALDH1A1 (0.41) | POLBTDP1APEX1ALDH1A1CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4640736-A1 | RING-OPENED COPOLYMER, RUBBER COMPOSITION, RUBBER CROSS-LINKED PRODUCT, AND TIRE | Zeon Corporation (JP) | 2025-10-29 | — | — | EP | disclosed |
| US-20250215136-A1 | RUBBER COMPOSITION AND CROSSLINKED RUBBER PRODUCT | ZEON CORPORATION (JP) | 2025-07-03 | — | — | US | disclosed |
| US-20250215137-A1 | COPOLYMER, RUBBER COMPOSITION AND CROSSLINKED RUBBER | ZEON CORPORATION (JP) | 2025-07-03 | — | — | US | disclosed |
| WO-2025100025-A1 | TREAD RUBBER COMPOSITION, TREAD RUBBER, AND TIRE | 株式会社ブリヂストン | 2025-05-15 | — | — | WO | disclosed |
| WO-2025070000-A1 | RUBBER COMPOSITION, CROSSLINKED RUBBER, AND TIRE | 日本ゼオン株式会社 | 2025-04-03 | — | — | WO | disclosed |
| US-20250091969-A1 | CYCLOPENTENE RECOVERY METHOD | ZEON CORPORATION (JP) | 2025-03-20 | — | — | US | disclosed |
| EP-4502059-A1 | RUBBER COMPOSITION AND CROSSLINKED RUBBER PRODUCT | Zeon Corporation (JP) | 2025-02-05 | — | — | EP | disclosed |
| EP-4502014-A1 | COPOLYMER, RUBBER COMPOSITION AND CROSSLINKED RUBBER | Zeon Corporation (JP) | 2025-02-05 | — | — | EP | disclosed |
| EP-4502058-A1 | RUBBER COMPOSITION AND CROSSLINKED RUBBER OBJECT | Zeon Corporation (JP) | 2025-02-05 | — | — | EP | disclosed |
| WO-2025013873-A1 | CYCLOPENTENE RECOVERY METHOD | 日本ゼオン株式会社 | 2025-01-16 | — | — | WO | disclosed |
| WO-2025004406-A1 | RUBBER COMPOSITION FOR TIRE, AND TIRE | 株式会社ブリヂストン | 2025-01-02 | — | — | WO | disclosed |
| WO-2025004407-A1 | RUBBER COMPOSITION FOR TIRES, AND TIRE | 株式会社ブリヂストン | 2025-01-02 | — | — | WO | disclosed |
| WO-2025004409-A1 | TIRE RUBBER COMPOSITION AND TIRE | 株式会社ブリヂストン | 2025-01-02 | — | — | WO | disclosed |
| WO-2025004404-A1 | RUBBER COMPOSITION FOR TIRES, AND TIRE | 株式会社ブリヂストン | 2025-01-02 | — | — | WO | disclosed |
| WO-2025004405-A1 | RUBBER COMPOSITION FOR TIRE AND TIRE | 株式会社ブリヂストン | 2025-01-02 | — | — | WO | disclosed |
| WO-2025004408-A1 | RUBBER COMPOSITION FOR TIRE, AND TIRE | 株式会社ブリヂストン | 2025-01-02 | — | — | WO | disclosed |
| EP-4461720-A1 | CYCLOPENTENE RECOVERY METHOD | Zeon Corporation (JP) | 2024-11-13 | — | — | EP | disclosed |
| WO-2024135347-A1 | RING-OPENED COPOLYMER, RUBBER COMPOSITION, RUBBER CROSS-LINKED PRODUCT, AND TIRE | 日本ゼオン株式会社 | 2024-06-27 | — | — | WO | disclosed |
| WO-2023189495-A1 | RUBBER COMPOSITION AND CROSSLINKED RUBBER OBJECT | 日本ゼオン株式会社 | 2023-10-05 | — | — | WO | disclosed |
| WO-2023189497-A1 | COPOLYMER, RUBBER COMPOSITION AND CROSSLINKED RUBBER | 日本ゼオン株式会社 | 2023-10-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250091969-A1 | CYCLOPENTENE RECOVERY METHOD | CYC1, CYCS, DHPS | POLB 1140/4885TDP1 809/4885APEX1 24/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.